載入...
Contemporary Trends and Outcomes Associated with the Pre-Procedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
OBJECTIVES: We sought to describe trends in the use of pre-procedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI). BACKGROUND: Oral P2Y12 inhibitors are ubiquitously used medications; however, the specific timing of initial P2Y12 inhibit...
Na minha lista:
| 發表在: | J Invasive Cardiol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5699908/ https://ncbi.nlm.nih.gov/pubmed/28420804 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|